Navigation Links
A new vaccine for leukemia

A new vaccine has been developed by a research team from Southampton University,which works by instigating the body's immune system to fight lymphoma,a cancer of the immune cells in the blood.//The lymphoma cells are not usually identified by the body's immune system, and so can multiply diversely.

By, using the new technique, scientists are able to remove a sample of tumour cells from a patient, and isolate the genetic material which identifies the cells as foreign bodies.This material is then multiplied in the test tube and combined with part of the toxin which causes tetanus. It is then re-injected into the patient.

Head of the research team Professor Freda Stevenson said: "In theory tumour cells should be killed by the immune system because it is designated to destroy anything which is not a normal, healthy cell.However tumour cells are decieving. Though clearly labelled, they have developed ways of switching off the immune system to their presence, thwarting any possible attack.

Professor Stephenson plans to launch a 21-patient trial of the new vaccine within six months.She believes the treatment will be without side effects, and will offer the patient immunity against their cancer for life. It is hoped that the treatment can be refined and extended to other cancers of the blood - including myeloma and myeloid leukaemia.


'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. Shortage of MMR vaccine
10. Anthrax vaccine produced
11. Problematic Use of smallpox vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... VATICAN CITY (PRWEB) , ... April 28, 2016 ... ... medicine is on the world stage this week. A group of researchers and ... Conference on the Progress of Regenerative Medicine and Its Cultural Impact ” and ...
(Date:4/28/2016)... ... 28, 2016 , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has ... be held at the University of Montana on April 28-May 1. Varize will compete ... , In order to qualify, Varize needed to place top seven all-around in her ...
(Date:4/28/2016)... ... 2016 , ... Cosmetic Town, an online plastic surgery community, announces the relaunch ... recently revamped and upgraded to allow even more interaction between doctors and patients as ... According to the senior editor of Cosmetic Town, “We are excited that our ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine ... the emerging field of biomechatronics, technology that marries human physiology with electromechanics. He continues ... He is also the Founder of BionX , a leader in the field ...
(Date:4/28/2016)... ... ... One way to ignore solid evidence is to dismiss research because, “it ... baby out with the bathwater when we ignore all studies because some are fatally ... making better use of education policy research. , “When readers heed basic cautions, research ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... 2016 TapImmune,Inc. (TPIV), a ... and gene-based immunotherapeutics and vaccines for the treatment of cancer ... the 3rd Annual Growth Capital Expo to be ... at Caesars Palace in Las Vegas, Nevada.  The Company ... 4 th by Dr. John N. Bonfiglio ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: